Companies / CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc.
CLCDCIK 1348649
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 11, 2015 | DP VI Associates, L.P. Director | Other Derivative conversion | Common Stock | $0 | +4K | 3,519 | low |
| May 11, 2015 | Domain Partners VI, L.P. 10% owner | Other Derivative conversion | Common Stock | $0 | +2.2M +5043.01% | 2,245,902 | low |
| May 11, 2015 | DP VI Associates, L.P. Director | Other Derivative conversion | Series B Preferred Stock | — | -2K -100.00% | 0 | low |
| May 11, 2015 | DP VI Associates, L.P. Director | Other Derivative conversion | Series A Preferred Stock | — | -2K -100.00% | 0 | low |
| May 11, 2015 | Domain Partners VI, L.P. 10% owner | Other Derivative conversion | Series C Preferred Stock | — | -465K -100.00% | 0 | low |
| May 11, 2015 | Domain Partners VI, L.P. 10% owner | Other Derivative conversion | Series B Preferred Stock | — | -939K -100.00% | 0 | low |
| May 11, 2015 | Domain Partners VI, L.P. 10% owner | Other Derivative conversion | Series A Preferred Stock | — | -798K -100.00% | 0 | low |
| Jan 12, 2015 | Treu Jesse I Director | Other Other (per filing) | Series B Preferred Stock | — | +753K +403.36% | 939,289 | low |